The company is committed to leveraging its extensive resources across the enterprise to innovate and execute with excellence, ensuring a focus on addressing the unmet needs of society and investing for an enduring impact. The executive committee oversees and coordinates the activities of the consumer health, pharmaceutical, and medical devices business segments, which allows for effective resource allocation and management capability. The competitive environment necessitates substantial investments in research and development, reflecting management's commitment to create life-enhancing innovations and partnerships that will profoundly change the trajectory of health for humanity. The company has seen a market recovery in global procedural volumes in the medical devices segment, which is a critical driver of sales and earnings growth. The company’s research and development activities represent a significant part of its business, focusing on discovering, testing, and developing new products while ensuring product efficacy and regulatory compliance. The company remains committed to investing in research and development, with an increase in expenditures driven by general portfolio progression and the impact of COVID-19 vaccine expenses. The company has also established a global vaccine supply network, which involves multiple manufacturing sites to ensure adequate production capacity. The company’s operational flexibility and agility are enhanced by its diversified business model, which includes strategic collaborations and initiatives aimed at reducing complexity and improving cost-competitiveness. The company’s ability to mobilize and deploy IT-based resources in combination with other capabilities is crucial for transforming into a competitive force. The development and maintenance of customer demand for the company's consumer products involve significant expenditures for advertising and promotion, further emphasizing the importance of effective information management capability. The company’s commitment to creating value through innovative products and services is reflected in the introduction of new products, which accounted for a substantial portion of sales. The company’s strategic management practices are designed to enhance organizational effectiveness and agility, enabling it to respond to market dynamics and external influences effectively. The company’s investment in technology capabilities, including digital infrastructure and IT systems, supports its operational efficiency and enhances its competitive positioning in the marketplace. The company’s governance contexts and strategic resource allocation are aligned with its objectives to create business value and improve performance outcomes. The ongoing assessment of the impact of COVID-19 on the company's operations highlights the importance of robust business continuity plans and the ability to adapt to changing market conditions. The company’s financial performance is supported by its strong liquidity position and access to capital markets, which provide the necessary resources to fund ongoing operational needs and strategic initiatives. The company continues to monitor global economic conditions and regulatory changes that may affect its operations, ensuring it remains responsive to environmental factors and consumer demands.